Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.0B | 3.3B | 3.6B | 3.2B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 160M | 207M | 143M | 146M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | 0 | 0 | 0 | 0 |
| Pretax income | 236M | 289M | 376M | 185M |
| Tax provision | 70M | 84M | 106M | 61M |
| Net income | 347M | 222M | 318M | 35M |
| Basic EPS | 0.2 | 0.1 | 0.2 | 0.1 |
| Diluted EPS | 0.2 | 0.1 | 0.2 | 0.1 |
| Basic average shares | 1.5B | 1.5B | 1.5B | 1.5B |
| Diluted average shares | 1.5B | 1.5B | 1.5B | 1.5B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |